PT3613739T - Integrin antagonists - Google Patents
Integrin antagonistsInfo
- Publication number
- PT3613739T PT3613739T PT191924026T PT19192402T PT3613739T PT 3613739 T PT3613739 T PT 3613739T PT 191924026 T PT191924026 T PT 191924026T PT 19192402 T PT19192402 T PT 19192402T PT 3613739 T PT3613739 T PT 3613739T
- Authority
- PT
- Portugal
- Prior art keywords
- integrin antagonists
- integrin
- antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18194258 | 2018-09-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3613739T true PT3613739T (en) | 2020-12-09 |
Family
ID=63579186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT191924026T PT3613739T (en) | 2018-09-13 | 2019-08-19 | Integrin antagonists |
Country Status (4)
| Country | Link |
|---|---|
| EA (1) | EA202190428A1 (en) |
| HR (1) | HRP20201912T1 (en) |
| MA (1) | MA51342B1 (en) |
| PT (1) | PT3613739T (en) |
-
2019
- 2019-08-19 EA EA202190428A patent/EA202190428A1/en unknown
- 2019-08-19 MA MA51342A patent/MA51342B1/en unknown
- 2019-08-19 PT PT191924026T patent/PT3613739T/en unknown
-
2020
- 2020-12-01 HR HRP20201912TT patent/HRP20201912T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA51342A (en) | 2020-02-26 |
| MA51342B1 (en) | 2020-12-31 |
| EA202190428A1 (en) | 2021-06-21 |
| HRP20201912T1 (en) | 2021-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202101913PA (en) | INHIBITING aV ß6 INTEGRIN | |
| EP3860977A4 (en) | Integrin antagonists | |
| ZA202101406B (en) | Integrin antagonists | |
| SG11201609614QA (en) | α4β7 INTEGRIN THIOETHER PEPTIDE ANTAGONISTS | |
| SI3515887T1 (en) | Trpv4 antagonists | |
| EP3481814A4 (en) | Tetrahydronaphthyridinepentanamide integrin antagonists | |
| GB201717974D0 (en) | Modified receptors | |
| GB201905552D0 (en) | Antagonists | |
| IL267686A (en) | Integrin antagonists | |
| IL274751A (en) | Ildr2 antagonists and combinations thereof | |
| IL292692A (en) | Mrgprx2 antagonists and uses thereof | |
| SG11202002207QA (en) | Trpv2 antagonists | |
| GB201815629D0 (en) | Antagonists | |
| GB201820458D0 (en) | Ox1 antagonists | |
| IL292693A (en) | Mrgprx2 antagonists and uses thereof | |
| PT3613739T (en) | Integrin antagonists | |
| GB201718256D0 (en) | Ox1 antagonists | |
| GB201707499D0 (en) | Orexin receptor antagonists | |
| GB201702174D0 (en) | Orexin receptor antagonists | |
| IL283413A (en) | Antagonists | |
| ZA201807767B (en) | Angiotensin-1-receptor antagonists | |
| GB201908621D0 (en) | Construction set | |
| SI3695039T1 (en) | Reinforced nonwoven | |
| PT3464324T (en) | Angiotensin-1-receptor antagonists | |
| GB201719750D0 (en) | Local area network |